Gujarat Themis Biosyn Stock Screener | Share Price & Fundamental Analysis
GUJTHEM
Pharmaceuticals
Share Price NSE
₹261.18
▲
9.87 (3.93%)
Share Price BSE
₹261.05
▲
9.55 (3.80%)
Track Gujarat Themis Biosyn share price live with TickJournal's free stock screener.
Analyze Gujarat Themis Biosyn share price history trends and compare 52-week high low
levels.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
Gujarat Themis Biosyn Market Cap
₹2,738.41 Cr.
GUJTHEM P/E Ratio (TTM)
57.29
Gujarat Themis Biosyn P/B Ratio
10.36
EPS (TTM)
₹4.48
Dividend Yield
0.27%
Debt to Equity
0.07
GUJTHEM 52 Week High
₹469.90
Gujarat Themis Biosyn 52 Week Low
₹226.90
Operating Margin
45.00%
Profit Margin
29.63%
GUJTHEM Revenue (TTM)
₹162.00
EBITDA
₹75.00
Net Income
₹48.00
Total Assets
₹301.00
Total Equity
₹248.00
Gujarat Themis Biosyn Share Price History - Stock Screener Chart
Screen GUJTHEM historical share price movements with interactive charts. Analyze price trends and patterns.
Gujarat Themis Biosyn Company Profile - Fundamental Screener
Screen Gujarat Themis Biosyn company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for GUJTHEM shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE942C01045
Gujarat Themis Biosyn Balance Sheet Screener
Screen GUJTHEM balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 301 | 221 | 166 | 123 | 88 | 64 | 33 | 21 | 21 | 15 |
| Current Assets | 52 | 48 | 62 | 78 | 63 | 29 | 8 | 8 | 8 | 3 |
| Fixed Assets | 41 | 38 | 33 | 19 | 19 | 17 | 15 | 11 | 11 | 9 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 32 | 4 | 2 | 2 | 3 | 5 | 1 | 1 | 1 | 2 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 248 | 201 | 149 | 103 | 70 | 42 | 19 | 12 | 8 | 4 |
| Share Capital | 11 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves & Surplus | 238 | 194 | 142 | 96 | 63 | 35 | 11 | 5 | 1 | -3 |
Gujarat Themis Biosyn Income Statement Screener - Profit & Revenue Analysis
Screen Gujarat Themis Biosyn income statement and profit fundamentals.
Analyze GUJTHEM quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Gujarat Themis Biosyn share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 162 | 153 | 174 | 155 | 119 | 94 | 87 | 43 | 39 | 36 | 33 | 32 |
| Expenses | 87 | 81 | 91 | 75 | 57 | 50 | 53 | 34 | 33 | 30 | 27 | 25 |
| EBITDA | 75 | 71 | 83 | 80 | 62 | 44 | 34 | 10 | 6 | 6 | 6 | 6 |
| Operating Profit % | 45.00% | 46.00% | 46.00% | 50.00% | 51.00% | 45.00% | 37.00% | 18.00% | 16.00% | 17.00% | 19.00% | 20.00% |
| Depreciation | 10 | 5 | 4 | 3 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 64 | 66 | 79 | 78 | 59 | 41 | 31 | 8 | 5 | 5 | 5 | 5 |
| Tax | 12 | 17 | 20 | 20 | 15 | 11 | 8 | 2 | 1 | 1 | 0 | 0 |
| Net Profit | 48 | 49 | 59 | 58 | 44 | 30 | 24 | 6 | 4 | 4 | 5 | 5 |
| EPS | 4.40 | 4.48 | 40.72 | 39.90 | 30.03 | 20.77 | 16.30 | 4.41 | 2.66 | 3.01 | 3.19 | 3.16 |
Gujarat Themis Biosyn Cash Flow Screener - Liquidity Fundamentals
Screen GUJTHEM cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 91 | 64 | 40 | 40 | 11 | 1 | 1 | 6 | 3 | 4 |
| Investing Activities | -112 | -55 | -20 | -30 | -2 | -3 | -6 | -1 | -3 | -1 |
| Financing Activities | 26 | -9 | -13 | -14 | -5 | 2 | 5 | -4 | 0 | -3 |
| Net Cash Flow | 5 | 0 | 6 | -4 | 3 | 0 | 0 | 1 | 0 | 0 |
Gujarat Themis Biosyn Shareholding Pattern Screener
See Gujarat Themis Biosyn shareholding pattern with promoter, FII, and DII holdings.
Check Gujarat Themis Biosyn promoter holding and ownership changes for GUJTHEM on TickJournal.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2025-Feb | 2024-Dec | 2024-Sept | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 70.86% | 70.86% | 70.86% | 70.86% | 70.86% | 70.86% | 70.86% | 70.86% |
| FII Holding | 1.96% | 2.95% | 2.51% | 1.91% | 0.00% | 1.42% | 1.49% | 1.44% |
| DII Holding | 1.17% | 1.17% | 1.17% | 1.17% | 1.16% | 1.17% | 1.17% | 1.18% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 19.90% | 18.72% | 19.31% | 19.66% | 19.75% | 20.12% | 20.44% | 21.17% |
| Other Holding | 6.10% | 6.29% | 6.14% | 6.39% | 8.22% | 6.42% | 6.03% | 5.35% |
| Shareholder Count | 27,325 | 28,319 | 28,945 | 30,673 | 30,695 | 30,934 | 31,271 | 30,280 |
Gujarat Themis Biosyn Share Dividend Screener - Share Yield Analysis
Check Gujarat Themis Biosyn dividend history with payout and yield data.
View Gujarat Themis Biosyn dividend details including ex-dates and amounts for GUJTHEM stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.67 | 0.30% |
| 2024-March | ₹1.00 | 0.35% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Gujarat Themis Biosyn Stock Index Membership
See which indices include Gujarat Themis Biosyn stock.
Check GUJTHEM index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE INDEX BSE HC
BSE INDEX SMLCAP
Gujarat Themis Biosyn Market Events Screener - Corporate Actions
Get Gujarat Themis Biosyn corporate actions including splits, bonuses, and buybacks.
Check Gujarat Themis Biosyn stock events that may affect GUJTHEM share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 5.18% | ||
| Dividend | ₹ 1.00 /share | 1.31% | ||
| Dividend | ₹ 0.67 /share | 14.14% | ||
| 2026-02-05 | 2026-02-05 | Quarterly Result Announcement | NA | 6.98% |
| 2025-11-10 | 2025-11-10 | Quarterly Result Announcement | NA | -2.76% |
| 2025-08-01 | 2025-08-01 | Quarterly Result Announcement | NA | 7.60% |
| 2025-05-20 | 2025-05-20 | Quarterly Result Announcement | NA | 6.23% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -12.92% |
| 2024-10-25 | 2024-10-25 | Quarterly Result Announcement | NA | -7.92% |
| 2024-08-09 | 2024-08-09 | Bonus | 1:2 | 3.18% |
| 2024-07-23 | 2024-07-23 | Annual General Meeting | NA | 15.98% |
| 2024-07-15 | 2024-07-16 | Dividend | ₹ 0.25 /share | 20.54% |
| 2024-02-22 | 2024-02-22 | Dividend | ₹ 0.75 /share | -2.29% |
| 2023-10-10 | 2023-05-13 | Split | 1:5 | 0.00% |
| 2022-12-01 | 2022-12-02 | Dividend | ₹ 4.40 /share | -9.39% |
Gujarat Themis Biosyn Competitors Screener - Peer Comparison
Screen GUJTHEM competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 404,120 | 37.12 | 54,729 | 9.71% | 10,980 | 37.98 |
| Divis Laboratories | 155,565 | 62.72 | 9,712 | 18.67% | 2,191 | 33.24 |
| Torrent Pharmaceuticals | 134,945 | 59.42 | 11,539 | 6.99% | 1,911 | 32.75 |
| Lupin | 103,753 | 22.29 | 22,910 | 13.74% | 3,306 | 47.35 |
| Dr Reddys Laboratories | 101,835 | 18.40 | 33,741 | 16.73% | 5,725 | 39.36 |
| Cipla | 96,150 | 21.27 | 28,410 | 7.12% | 5,291 | 26.86 |
| Zydus Life Science | 87,542 | 17.30 | 23,511 | 18.55% | 4,615 | 41.42 |
| Mankind Pharma | 82,586 | 45.73 | 12,744 | 20.90% | 2,007 | 41.40 |
| Aurobindo Pharma | 78,060 | 22.27 | 32,346 | 9.43% | 3,484 | 64.38 |
| Alkem Laboratories | 63,053 | 25.95 | 13,458 | 3.70% | 2,216 | 42.54 |
Gujarat Themis Biosyn Company Announcements - News Screener
Screen GUJTHEM latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-03-24 | Closure of Trading Window | - |
| 2026-03-19 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-03-18 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | - |
| 2026-02-07 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-02-07 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | - |
| 2026-02-06 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-05 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-02-05 | Results - Financial Results For The Quarter And Nine Months Ended 31.12.2025 | - |
| 2026-02-05 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-02-05 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-02-05 | Board Meeting Outcome for Outcome Of The Board Meeting Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations) | - |
| 2026-01-31 | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | - |
| 2026-01-30 | Board Meeting Intimation for Approval Of Financial Results For The Quarter And Nine Months Ended 31St December 2025 | - |
| 2026-01-20 | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | - |
| 2026-01-14 | General-Updates: Report On Special Window For Re-Lodgment Of Transfer Requests Of Physical Shares. | - |
| 2026-01-14 | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | - |
| 2026-01-08 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-01-07 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | - |
| 2026-01-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-01-03 | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | - |